Skip to main content
Top
Published in: European Journal of Nutrition 2/2021

01-03-2021 | Gestational Diabetes | Original Contribution

Soy consumption and incidence of gestational diabetes mellitus: the Japan Environment and Children’s Study

Authors: Jia-Yi Dong, Takashi Kimura, Satoyo Ikehara, Meishan Cui, Yoko Kawanishi, Tadashi Kimura, Kimiko Ueda, Hiroyasu Iso, for the Japan Environment and Children’s Study Group

Published in: European Journal of Nutrition | Issue 2/2021

Login to get access

Abstract

Background

Intervention studies have shown that isoflavone treatment improved glucose metabolism, indicating that soy intake may have a potential role in diabetes prevention.

Objectives

We aimed to investigate the prospective association of soy isoflavone and soy food intakes with incidence of gestational diabetes mellitus (GDM) in a birth cohort study.

Methods

We recruited 97,454 pregnant women (median gestational age 12 weeks) between January 2011 and March 2014. Dietary intakes during the 12 months preceding study enrollment were assessed by a semi-quantitative food frequency questionnaire. The relative risks of GDM associated with soy isoflavone and soy food intakes were obtained by Poisson regression. Demographic information, histories of diseases, socioeconomic status, lifestyles, and dietary habits, obtained by a self-administrated questionnaire, were used for covariate adjustments.

Results

We identified 1904 cases of GDM (2.2%) among 84,948 women. Compared with those in the lowest quintile of soy isoflavone intake, women in the highest quintile were found to have experienced a significantly lower risk of GDM (multivariate relative risk = 0.82; 95% confidence interval: 0.70, 0.95; P for trend = 0.05). Similar results were observed for genistein and daidzein. Regarding soy foods, intakes of miso soup and natto were inversely associated with GDM incidence (both P for trend ≤ 0.01), whereas the association for tofu intake appeared to be nonlinear (P for trend = 0.74).

Conclusions

Higher intakes of miso soup and natto before and during early pregnancy, compared with lower intakes, may be associated with a lower incidence of GDM.
Appendix
Available only for authorised users
Literature
2.
go back to reference Dong JY, Qin LQ (2011) Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125:315–323CrossRef Dong JY, Qin LQ (2011) Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125:315–323CrossRef
22.
go back to reference Yokoyama Y, Takachi R, Ishihara J et al (2016) Validity of short and long self-administered food frequency questionnaires in ranking dietary intake in middle-aged and elderly japanese in the japan public health center-based prospective study for the next generation (JPHC-NEXT) protocol area. J Epidemiol 26:420–432. https://doi.org/10.2188/jea.JE20150064CrossRefPubMed Yokoyama Y, Takachi R, Ishihara J et al (2016) Validity of short and long self-administered food frequency questionnaires in ranking dietary intake in middle-aged and elderly japanese in the japan public health center-based prospective study for the next generation (JPHC-NEXT) protocol area. J Epidemiol 26:420–432. https://​doi.​org/​10.​2188/​jea.​JE20150064CrossRefPubMed
27.
go back to reference Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162:199–200CrossRef Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162:199–200CrossRef
31.
33.
go back to reference Crisafulli A, Altavilla D, Marini H et al (2005) Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 12:186–192CrossRef Crisafulli A, Altavilla D, Marini H et al (2005) Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 12:186–192CrossRef
40.
go back to reference Hiramatsu Y, Haneda M, Yasuhi I et al (2015) The joint committee with the Japan Society of Diabetes and Pregnancy and the Japan Diabetes Society “an abnormal glucose metabolism during pregnancy and the standardization of its diagnostic criteria”. J Japan Diabetes Soc 58:801–803. https://doi.org/10.11213/tonyobyo.58.801 (in Japanese)CrossRef Hiramatsu Y, Haneda M, Yasuhi I et al (2015) The joint committee with the Japan Society of Diabetes and Pregnancy and the Japan Diabetes Society “an abnormal glucose metabolism during pregnancy and the standardization of its diagnostic criteria”. J Japan Diabetes Soc 58:801–803. https://​doi.​org/​10.​11213/​tonyobyo.​58.​801 (in Japanese)CrossRef
Metadata
Title
Soy consumption and incidence of gestational diabetes mellitus: the Japan Environment and Children’s Study
Authors
Jia-Yi Dong
Takashi Kimura
Satoyo Ikehara
Meishan Cui
Yoko Kawanishi
Tadashi Kimura
Kimiko Ueda
Hiroyasu Iso
for the Japan Environment and Children’s Study Group
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2021
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02294-1

Other articles of this Issue 2/2021

European Journal of Nutrition 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.